Sr. Director, R&D Finance FP&A and Portfolio

Sr. Director, R D Finance FP&A and Portfolio Employer Legend Biotech Location Bridgewater, New Jersey Salary $187989 - $246735 Start date Apr 21, 2026 View more categories View less categories Discipline Administration , Finance , Science/R D , Research Required Education Bachelors Degree Position Type Full time Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Send job Job Details Company Job Details Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide. Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma. Legend Biotech is seeking a Sr. Director, R D Finance FP&A and Portfolio as part of the Finance team based in Bridgewater, NJ . Role Overview A key member in the Pipeline Finance team, serving as the dedicated financial partner for the Pipeline functions, leading Finance Analyst in Data Management, Reporting and Dashboarding, and Analytics support senior management decision making. Based in the US, this role reports directly to the Pipeline Finance Head. This role will take charge of end-to-end financial planning, budgeting, forecasting and analysis work in the R D field, support the establishment and optimization of a standardized FP&A system, provide professional financial support for the implementation of R D strategies, optimal allocation of resources and investment decisions, collaborate effectively with cross-functional teams, and ensure that the R D financial FP&A work is aligned with the overall financial strategy of Legend and Pipeline BU. It translates Pipeline strategy into actionable plans for Pipeline projects, provides tailored financial analysis, budgeting and forecasting, and collaborates with Pipeline leadership, other FP&A colleagues and Pipeline Finance Analysts to ensure financial alignment and data-driven decisions. The Ideal candidate should have pharmaceutical/biotech FP&A experience with RD familiarity, strong strategic thinking, data analysis and independent work abilities. Must be US-based, able to collaborate cross-functionally in a matrix environment, and support RD Finance strategy execution. The ideal candidate will have a strong track record of driving improved financial performance, enhancing productivity, strengthening internal controls, and advancing systems and processes. Success requires high learning agility, the ability to collaborate across diverse and geographically dispersed teams, and skill navigating a complex, matrixed environment. Strong leadership is essential to support business decision-making and ensure smart resource allocation across the R D pipeline. Key Responsibilities Strategy & Portfolio Financial Leadership Support RD Finance Head in defining the financial strategy for Pipeline BU, as well as the overall development portfolio, including resource allocation across the pipeline. Align Pipeline Finance strategy with Pipeline needs, support FP&A process optimization and standardize best practices across projects and therapeutic areas. Provide strategic financial input into the Pipeline Strategy and business plan, enhancing transparency of cost, value, and return on investment. FP&A Execution & Budget Management Develop operating plans and budgets that support timely and high-quality delivery of business objectives, including benchmarking and tracking efficiency improvements. Take charge of budget preparation, review, consolidation and variance analysis, ensuring alignment with R D strategy and Pipeline priorities. Regularly report budget execution, forecast deviations and performance to the RD Finance Head with targeted insights. Consolidation, Analytics, Financial Analysis & Decision Support Leading RD Finance consolidation, data management, reporting and analytics. Conduct RD-focused financial analysis (cost, ROI, resource efficiency) and apply advanced financial skills to address early development uncertainty. Partner with Pipeline leadership team to support project prioritization, resource allocation and investment decisions, maximizing portfolio value. Track Pipeline financial KPIs, establish performance measurement frameworks, analyze deviations and propose improvement measures to drive continuous improvement. Ensure high-quality financial evaluations for investment decisions and prepare robust financial materials for Senior Executive Team review. Cost Control & Compliance Manage budget execution, warn of risks, coordinate corrective actions and control costs to ensure operational plans remain within established budgets. Identify cost optimization opportunities and support implementation to enhance resource utilization efficiency. Maintain accountability for SOX and FCF controls, ensure FP&A compliance with Finance Standards, policies and relevant global clinical trial accounting policies. Collaboration & Process Enhancement Collaborate with the Pipeline team to understand business needs and resolve financial collaboration issues. Coordinate with other FP&A colleagues and RD Finance Analysts for data/report support, aligning ways of working. Identify and support partnership opportunities and external collaborations to enable portfolio growth. Develop and optimize FP&A processes that effectively support evolving R D and Pipeline business needs, contributing to global policy/program implementation Requirements Bachelor's degree in Finance, Accounting, Business Administration, or a related field. MBA, CPA, or CMA is a plus. 15+ years of progressive FP&A experience, preferably in the biotech/pharmaceutical industry, with specific experience supporting R D functions. Demonstrates expertise in financial modeling, budgeting, and forecasting. Advanced proficiency in Excel (Pivot tables, macros, data modeling). Expertise in Anaplan (as the SME) and familiarity with ERP systems (e.g., SAP). Experience with data visualization tools (e.g., Tableau, Power BI). #Li-LB1 #Li-Hybrid The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.

Other Types of Pay:

Performance-based bonus and/or equity is available to employees in eligible roles.

Benefits and Paid Time Off:

Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short- and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance. We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work. Pay Range (Base Pay): $187,989 - $246,735 USD Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech. EEO Statement It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances. Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company. For information related to our privacy notice, please review: Legend Biotech Privacy Notice . Company Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap. For two years, Legend Biotech, then known as the "Legend Project," operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies. In 2015, Legend's scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China. In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world.

CARVYKTI

™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022. Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies. Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies. Company info Location Somerset New Jersey United States Share this job Facebook Twitter LinkedIn Apply now Send job Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Get job alerts Create a job alert and receive personalized job recommendations straight to your inbox. Create alert